Home > Healthcare > Medical Devices > Diagnostic Devices > Premature Rupture of Membranes (PROM) Testing Market

Premature Rupture of Membranes (PROM) Testing Market Size

Report ID: GMI5895
Published Date: May 2023
Report Format: PDF

Download Free Sample

Premature Rupture of Membranes Testing Market Size

Premature Rupture of Membranes (PROM) Testing Market size was valued at over USD 3 billion in 2022 and is estimated to grow at a 5.7% CAGR between 2023 to 2032. Premature rupture of membranes (PROM) diagnostic techniques and instruments are used to find and evaluate foetal membrane rupture prior to the beginning of labour. The aim of PROM testing is to verify the membrane rupture, diagnose the severity of the disease, and determine the most appropriate line of treatment for the patient.

To get key market trends

Download Free Sample

Increasing awareness about PROM-related complications, advancements in diagnostic technologies are few aspects driving the growth of the premature rupture of membranes testing industry during projected timeframe.

Moreover, continuous growth in the prevalence rate of preterm births is further augmenting the growth of the premature rupture of membranes (PROM) testing market. For instance, according to the World Health Organization (WHO), more than 15 million new-borns are born preterm. Also, around 1 million deaths are associated with preterm complications each year across the world. As preterm birth is a risk factor for PROM, the increasing prevalence of preterm births directly contributes to the higher demand for PROM testing and the development of innovative testing technologies, including advanced diagnostic tools and improved methodologies, to meet the growing demand.

Premature Rupture of Membranes (PROM) Testing Market Report Attributes
Report Attribute	Details
Base Year:	2022
Premature Rupture of Membranes (PROM) Testing Market Size in 2022:	USD 2.9 Billion
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	5.4%
2032 Value Projection:	USD 4.9 Billion
Historical Data for:	2018 to 2022
No. of Pages:	145
Tables, Charts & Figures:	195
Segments covered:	Product Type, End-use, and Region
Growth Drivers:	Growing incidence of preterm births Increasing awareness of premature rupture of membranes Surge in prevalence of diabetes and cardiovascular diseases Rising development of new and improved diagnostic tests
Pitfalls & Challenges:	Lack of awareness regarding these tests High cost of tests

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Premature Rupture of Membranes Testing Market was valued at over USD 3 billion in 2022 and is projected to reach more than USD 5 billion by 2032 attributed to the increasing awareness about PROM-related complications and advancements in diagnostic technologies.

The nitrazine test segment is estimated to grow at 5.7% CAGR over 2023-2032 owing to ongoing technological advancements and integration of digital solutions in nitrazine tests to enhance accuracy, ease of use, and interpretation.

The U.S. premature rupture of membranes (PROM) testing market amassed USD 1 billion in 2022 and is anticipated to grow at a robust CAGR through 2032 driven by the high prevalence of preterm births across the nation.

Abbott Laboratories, QIAGEN, Hologic Inc., Medix Biochemica, Biosynex, Clinical Innovations LLC, Sera Prognostics Inc., The Cooper Companies Inc., NX Prenatal Inc., and IQ Products are some of the leading firms in the global premature rupture of membranes (PROM) testing industry.